The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma

被引:1
|
作者
Ning, Zhong-Hua [1 ,2 ]
Zhao, Wei [3 ]
Li, Xiao-Dong [1 ]
Chen, Lu-Jun [1 ]
Xu, Bin [1 ]
Gu, Wen-Dong [2 ]
Shao, Ying-Jie [2 ]
Xu, Yun [1 ]
Huang, Jin [2 ]
Pei, Hong-Lei [2 ]
Jiang, Jing-Ting [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou 213003, Peoples R China
[2] Soochow Univ, Affiliated Hosp 3, Dept Radiat Oncol, Changzhou 213003, Peoples R China
[3] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou 213003, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 06期
基金
中国国家自然科学基金;
关键词
Biomarkers; perineural invasion; prognosis; esophageal squamous cell carcinoma; postoperative radiotherapy; PROSTATE-CANCER; NEURAL INVASION; CURATIVE RESECTION; PANCREATIC-CANCER; RADIATION-THERAPY; SURVIVAL; ADJUVANT; CHEMORADIOTHERAPY; NEOADJUVANT; STROMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prognosis of locally advanced esophageal squamous cell carcinoma (ESCC) remains dismal even after curative resection and adjuvant radiotherapy. New biomarkers for predicting prognosis and treatment outcomes are needed for improved treatment stratification of patients with locally advanced ESCC. The prognostic and treatment predictive significance of perineural invasion (PNI) in the locally advanced ESCC remains unclear. This study aimed to examine the effect of PNI on the outcomes of locally advanced ESCC patients after curative resection with or without postoperative radiotherapy (PORT). Patients and methods: We retrospectively reviewed 262 consecutive locally advanced ESCC patients who underwent curative resection. Tumors sections were re-evaluated for PNI by an independent pathologist blinded to the patients' outcomes. Overall survival (OS) and disease-free survival (DFS) were determined using the Kaplan-Meier method; univariate log-rank test and multivariate Cox proportional hazard model were used to evaluate the prognostic value of PNI. Results: Finally, 243 patients were analyzed and enrolled into this study, of which 132 received PORT. PNI was identified in 22.2% (54/243) of the pathologic sections. The 5-year DFS was favorable for PNI-negative patients versus PNI-positive patients (21.3% vs. 36.7%, respectively; P = 0.005). The 5-year OS was 40.3% for PNI-negative patients versus 21.7% for PNI-positive patients (P < 0.001). On multivariate analysis, PNI was an independent prognostic factor. In a subset analysis for patients received PORT, PNI was evaluated as a prognostic predictor as well (P < 0.05). In contrast to patients without PORT, PORT couldn't improve the disease recurrence and survival in locally advanced ESCC patients with PNI-positive (P > 0.05). Conclusions: PNI could serve as an independent prognostic factor and prognosticate treatment outcomes in locally advanced ESCC patients. The PNI status should be considered when stratifying high-risk locally advanced ESCC patients for adjuvant radiotherapy. Future prospective study is warranted to confirm our results.
引用
收藏
页码:6881 / 6890
页数:10
相关论文
共 50 条
  • [21] Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma
    Warren, Timothy A.
    Panizza, Benedict
    Porceddu, Sandro V.
    Gandhi, Mitesh
    Patel, Parag
    Wood, Martin
    Nagle, Christina M.
    Redmond, Michael
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (06): : 824 - 831
  • [22] Identification and Prognostic Effect of Extramural Venous Invasion in Locally Advanced Esophageal Squamous Cell Carcinoma
    Lin, Zhen
    Plukker, John T. M.
    Tian, Dong-ping
    Chen, Shao-bin
    Kats-Ugurlu, Gursah
    Su, Min
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2023, 47 (07) : 766 - 773
  • [23] Impact of Adjuvant Radiotherapy in Squamous Cell Carcinoma of the Oral Cavity with Perineural Invasion
    Festa, Bianca Maria
    Costantino, Andrea
    Pace, Gian Marco
    Petruzzi, Gerardo
    Campo, Flaminia
    Pellini, Raul
    Spriano, Giuseppe
    De Virgilio, Armando
    LARYNGOSCOPE, 2024, 134 (05): : 2019 - 2027
  • [24] Adjuvant radiotherapy for early head and neck squamous cell carcinoma with perineural invasion: A systematic review
    Bur, Andres M.
    Lin, Alexander
    Weinstein, Gregory S.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E2350 - E2357
  • [25] Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
    Li, Hui
    Gu, Dayong
    Du, Mingyu
    Zhou, Guoren
    Zhang, Zhi
    Ye, Jinjun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma
    Wu, Haishan
    Yu, Yilin
    Zheng, Qunhao
    Liu, Tianxiu
    Wu, Yahua
    Wang, Zhiping
    Zheng, Hongying
    Liu, Lingyun
    Li, Jiancheng
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [27] Concurrent liposomal paclitaxel and cisplatin chemotherapy improved outcomes for locally advanced esophageal squamous cell carcinoma treated with intensity-modulated radiotherapy
    Liu, Shu
    Ren, Sheng-Nan
    Ding, Wen-Xiu
    Ge, Xiao-Lin
    Cao, Yuan-Dong
    Zhang, Sheng
    Zhen, Fu-Xi
    Sun, Xin-Chen
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (14)
  • [28] Efficacy of postoperative radiotherapy in esophageal squamous cell carcinoma patients with positive circumferential resection margin
    Otake, Reiko
    Okamura, Akihiko
    Yamashita, Kotaro
    Imamura, Yu
    Kanamori, Jun
    Kozuki, Ryotaro
    Takahashi, Keita
    Toihata, Tasuku
    Yamamoto, Noriko
    Asari, Takao
    Mine, Shinji
    Watanabe, Masayuki
    ESOPHAGUS, 2021, 18 (02) : 288 - 295
  • [29] Serum squamous cell carcinoma antigen is a predictive factor of outcomes in patients with locally advanced unresectable esophageal squamous cell carcinoma treated by definitive chemoradiotherapy
    Suzuki, Takeshi
    Okamura, Akihiko
    Watanabe, Masayuki
    Asari, Takao
    Nakayama, Izuma
    Ogura, Mariko
    Ooki, Akira
    Takahari, Daisuke
    Yamaguchi, Kensei
    Chin, Keisho
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [30] Impact of Perineural Invasion and Preexisting Type 2 Diabetes on Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy
    Su, Nai-Wen
    Mok, Lai-Man
    Chan, Mei-Lin
    Liu, Hung-Chang
    Chang, Wei-Chin
    Yun, Chun-Ho
    Shieh, Tze-Yu
    Wu, Ming-Che
    Lin, Huan-Chau
    Huang, Wen-Chien
    Chen, Yu-Jen
    CANCERS, 2023, 15 (04)